论文信息 - Immunotherapy for sepsis--a new approach against an ancient foe.

Immunotherapy for sepsis--a new approach against an ancient foe.

A pathway newly implicated in the immunosuppression observed in persons infected with the human immunodeficiency virus (HIV) may also be pertinent to immunosuppression associated with sepsis.

R. Hotchkiss | S. Opal

[1] D. Douek,et al. Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection , 2010, Nature Medicine.

[2] S. Opal,et al. Antibiotic usage and resistance: gaining or losing ground on infections in critically ill patients? , 2009, JAMA.

[3] T. Baumann,et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. , 2009, American journal of respiratory and critical care medicine.

[4] C. Chung,et al. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis , 2009, Proceedings of the National Academy of Sciences.

[5] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.